vascular problems and judicious use or avoidance of nephrotoxic drugs such as aminoglycosides; many of the cases of acute renal failure seen today arise directly from doctor's actions (6) .
How the tubular necrosis comes about (3, 4, 7) , or even whether it is always present or is even the principal lesion, remains controversial. The renal tubules have a very high oxygen requirement, especially the thick ascending limb, and are thus very vulnerable to ischaemia. The cause of the persistently low volumes of urine, iso-osmolar with plasma but of very different and fixed composition, when renal bloodflow may be relatively well-preserved, also remains unknown. The simplest theory proposes simple blockage of tubules by debris from necrosed tubular cells, analogous to intratubular blockage from other substances such as insoluble sulphonamides. A more sophisticated variant of this theory proposes that in addition there is 'back-leak' of glomerular filtrate through the disrupted tubules (3) . A third theory suggests that the tubular damage leads to decreased reabsorption of sodium, which therefore reaches the distal nephron, and in particular the macula densa, in increased quantities (8) . The macula densa -a set of specialized tubular cells at the glomerular hilus -transmits a signal to the afferent arteriole to manufacture angiotensin II, constrict and thus limit glomerular filtration, which saves the patient from massive sodium loss.
Two particular problems which have become prominent recently in our thinking are the nonsteroidal anti-inflammatory drugs (NSAIDs) (9-11) and rhabdomyolysis, (12, 13) . Now that NSAIDs are available without prescription in both the United Kingdom and the United States, a large and unknown proportion of the population, especially the elderly, may be taking these drugs unknown to their physicians: it has been estimated that more than 30 million Americans are taking one or other preparation (9) . Their relevance to acute renal failure is twofold: first, several of this group of drugs appear to be capable of inducing an allergic interstitial nephritis, characterised by oedema and cellular infiltrate within the interstitium, acute oliguria and acute renal insufficiency (10) . This allergic interstititial nephritis has several other unusual features, in that some drugs, particularly fenoprofen, also induce profuse proteinuria which may provoke a full nephrotic syndrome. The renal failure induced may also be irreversible.
However, much more common and important are the effects of NSAIDs on renal bloodflow. In normal individuals with a normal circulating volume and renal perfusion, NSAIDs affect renal function little or not at all. However, in any state of renal underperfusion, whether from mild cardiac decompensation, volume depletion, salt loss, cirrhosis or a nephrotic syndrome, NSAIDs may cause a profound fall in renal bloodflow and in glomenilar filtration. The precise mechanism underlying this dangerous effect is not entirely clear, but it appears that vasodilator prostaglandins-in man principally PG12 (prostacyclin)-help, in states of renal hypoperfusion, to maintain cortical bloodflow and glomenilar filtration through effects on the intrarenal distribution of blood. States such as those listed are common in the elderly, and to these one must add volume depletion from the often inappropriate use of diuretics; the number of elderly people in the United Kingdom taking both diuretics and an NSAID is not known, but may be several million. Thus many hospitals are seeing an increasing number of old people with acute renal failure of apparently obscure origin, whose problems are at least in part due to consumption of NSAIDs.
It has been known for 50 years or more that free haemoglobin or intravascular haemolysis can lead to acute tubular necrosis, and up until 1950 mismatched transfusions were a relatively common form of acute renal failure. Happily this is no longer the case, but during the past 10 years it has become apparent that part of the reason for the classical acute renal failure following crush injuries, described by Eric Bywaters in the London 'Blitz' is the presence of free myoglobin in the circulation and glomenilar filtrate; indeed one of his papers illustrates the pigment within the tubules at post mortem (14) . The important new observation is how relatively common rhabdomyolysis may be (Table 2) (12, 13) . Whilst only a minority of patients with rhabdomyolysis actually go into acute renal failure (15) , and it is not clear whether myoglobin itself is toxic to the renal tubules, it is always worth screening patients with apparently obscure renal failure for free plasma myoglobin, or more conveniently by doing a creatine phosphokinase estimation to assess the degree of muscle breakdown. Sometimes only brief periods of unconsciousness from a variety of causes, including drugs and alcohol, can bring about profound rhabdomyolysis.
What is it that determines the poor prognosis of patients in renal failure? Nowadays no patient in acute renal failure should starve to death from lack of adequate nutrition, intravenous if needs be -as it usually is; unfortunately the huge energy requirements of uraemic septic traumatised patients, which may reach or exceed 5000 kcal/24 h are not always realised. Today, through the technique of continuous haemofiltration (16) , with or without occasional or regular haemodialysis, removing enough fluid to 'make space' for the large volumes of infusion required is no longer a problem. Equally, a common problem and cause of death in acute uraemia used to be massive upper gastrointestinal bleeding; better dialysis to control the uraemic state and better nutrition have probably contributed as much as prophylactic antacids and H2 antagonists to the virtual disappearance of this complication.
As well as being a major causative factor, the principal cause of death in acute renal failure is still sepsis (5, 17) . The uraemic state is one of profound immunosuppression, and antibiotics, whether used prophylactically or at need, seem to make little impact on the sepsis rate in patients with acute uraemia. Despite our ability to deal with Pseudomonas, anaerobes, even yeasts, our patients still die infected. The role of surgery should not be minimised here, since it is above all intra-abdominal sepsis (18, 24) which carries the highest mortality, even when it comes about after such relatively simple surgery as on the gall bladder; the abdomen may have to be re-opened repeatedly even though -in fact because -the patient is desperately ill.
However it is clear that in the majority of patients, by the time this point is reached, the stable door is wide open. How sepsis exerts its effects is still poorly understood. One major component is the endotoxin present in and released from many Gram-negative organisms, especially E. coli (5) . This is probably a major factor in the late, hypotensive vasocontricted stages of septic shock, although it does not seem to be involved in the early, dilated phase regularly seen in human sepsis (19) . Many adult individuals possess antibodies against endotoxin (20) , but many do not, and it has been argued that this is a critical determinant of survival in states of acute organ failure (5), and controversially that passive administration of antibodies to those deficient may improve survival in Gram-negative shock (21) . Assays for endotoxin until recently have been poorly standardised and difficult to perform, but the advent of radioimmunoassay should change this and make clinical study of endotoxaemia more easy.
A number of analyses of factors determining outcome have been carried out in patients with acute renal failure (22) (23) (24) (25) . Age has proven a surprisingly weak determinant of outcome, although most investigators find a higher mortality in their older patients. A maintained urine output of above 500 ml/24 h, even though the urine is of the same composition and has the same unresponsiveness to stimuli as in oliguric renal failure, is usually regarded as a milder form of acute tubular necrosis -'non-oliguric acute renal failure' (26) . Data from the EDTA-European Renal Association Registry, presented at the meeting of the Association in Brussels June 1985 Used with permission of Dr A. J. Wing and the Registry.
The most important feature determining prognosis is associated/a;/«re of other organ systems (25, (27) (28) (29) (30) . Recent data from the EDTA-European Renal Association (Table 3 ) (31) shows that of the few.patients(61 out of 474) in a recent European survey who had isolated acute renal failure, the mortality was only 8 per cent; thus patients with renal failure do not die of renal failure perse, exactly as one would expect in the age of renal replacement treatment. Conversely, the coincidence of one or more of pulmonary failure, circulatory failure, or liver failure raised the mortality abruptly to 70 per cent or more; in our own unit during 1984, the mortality of 29 patients who also required ventilation was 76 per cent (Taube, D, et al., unpublished data); 10 years ago the mortality was 91 per cent of 25 surgical patients. A crude count of the number of organ systems in failure (Table 4) gives an accurate if gloomy prognostic index (25, 28, 32) : if three or more systems are 'down' in current parlance, then the mortality rises towards 100 per cent. This is not only of purely medical importance, because these patients with multiple organ failure are very expensive to treat; no recent accurate costings from the United Kingdom exist, but previous American studies (27) and our own estimates suggest that these patients with multiple organ failure survive on average 20 to 30 days before dying, at an average cost of £40 000 to £50 000. If only one in four survives at best, in some categories even less, then the expenditure for each survivor may exceed a quarter of a million pounds on average. Our present inability to identify with certainty the potential survivors poses very difficult ethical and practical problems.
These considerations reinforce yet again the value of prevention; no figures for the incidence of acute renal failure exist, but in 1982 those renal units who provide data to the EDTAEuropean Renal Association's Registry reported a total of 1237 cases of acute renal failure (22.2 per million total population per year) for the United Kingdom (31); this is almost certainly an underestimate, because many patients with acute renal failure are managed outside the local renal unit, especially patients with milder disease who are treated using peritoneal dialysis. Thus we cannot say whether, for example, better use of fluid and colloid in surgical patients has diminished the number of patients actually going into renal failure after operations, although this improvement has been established for battle casualties (32) . What is abundantly clear is that efforts to prevent the establishment of acute tubular necrosis are worthwhile, given the appalling mortality once this particular Rubicon is crossed. The value of restoring an effective circulation seems certain; in some circumstances, such as jaundiced patients (33) and aortic surgery (34) , intravenous mannitol has been proved effective, but whether this effect is achieved by plasma volume expansion alone is not clear. Both frusemide (35) and low dose (1.5-5.0 ,u/kg/min) dopamine (36, 37) have advocates, although their value is unconfirmed. Meanwhile a number of newer approaches, of which the use of verapamil looks the most promising, are being evaluated in animal models.
Almost four decades have gone by without any real improvement in the outlook for patients with severe acute renal failure, ever since dialysis was first introduced to palliate their uraemia; let us hope a fifth decade will not pass in similar disappointment.
